What is Pieces?
Founded in 2015 and headquartered in Irving, Texas, Pieces Technologies, Inc. operates at the intersection of clinical research and data science. The company specializes in developing sophisticated software that interprets patient data in real-time, providing healthcare providers with the predictive tools necessary to enhance patient safety and community health outcomes. By analyzing both clinical data and environmental factors, Pieces offers a holistic view of patient health, enabling providers to intervene proactively rather than reactively. Its technology is designed to function seamlessly both within hospital walls and in broader community settings, making it a versatile asset for diverse healthcare systems.
How much funding has Pieces raised?
Pieces has raised a total of $73.3M across 4 funding rounds:
Series A
$21.6M
Series B
$25.7M
Debt
$1M
Private Equity
$25M
Series A (2016): $21.6M with participation from Pacific Advantage Capital, Children's Health, Parkland Center for Clinical Innovation, Order of Saint Francis Healthcare System, and Jump Capital
Series B (2020): $25.7M led by Concord Health Partners, OSF Healthcare System, and Children's Health of Dallas
Debt (2020): $1M supported by PPP
Private Equity (2024): $25M featuring Rittenhouse Ventures, OSF HealthCare, and Concord Health Partners
Key Investors in Pieces
Pacific Advantage Capital
A private investment partnership that invests globally across special situations, private equity, and growth equity, focusing on sectors that offer compelling risk-adjusted returns.
Children's Health
A private, not-for-profit, pediatric healthcare provider based in Dallas, Texas, offering specialized treatment and patient care across a wide range of medical disciplines.
Parkland Center for Clinical Innovation
An advanced, nonprofit healthcare analytics R&D organization that utilizes expert data scientists to provide all-encompassing insights into patient health and environmental factors.
What's next for Pieces?
With this latest capital injection, Pieces is well-positioned to scale its predictive analytics platform across a wider network of healthcare providers. The strategic focus will likely center on enhancing the interoperability of its warning tools and expanding its footprint in the digital health market. As the industry shifts toward value-based care, the demand for data-driven clinical decision support systems is expected to rise, providing Pieces with a significant competitive advantage. The company's ongoing collaboration with major health systems suggests a continued commitment to refining its algorithms and expanding its reach to improve patient care standards on a national scale.
See full Pieces company page
